Your browser doesn't support javascript.
loading
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.
Fizazi, Karim; Retz, Margitta; Petrylak, Daniel P; Goh, Jeffrey C; Perez-Gracia, Jose; Lacombe, Louis; Zschäbitz, Stefanie; Burotto, Mauricio; Mahammedi, Hakim; Gravis, Gwenaelle; Bastos, Diogo Assed; McCune, Steven L; Vázquez Limón, Juan Carlos; Kwan, Edmond M; Castellano, Daniel; Fléchon, Aude; Saad, Fred; Grimm, Marc-Oliver; Shaffer, David R; Armstrong, Andrew J; Bhagavatheeswaran, Prabhu; Amin, Neha P; Ünsal-Kaçmaz, Keziban; Wang, Xuya; Li, Jun; Loehr, Andrea; Pachynski, Russell K.
Afiliação
  • Fizazi K; Department of Cancer Medicine, Gustave Roussy, University Paris Saclay, Villejuif, France Karim.FIZAZI@gustaveroussy.fr.
  • Retz M; Department of Urology, Rechts der Isar Medical Center, Technical University Munich, Munich, Germany.
  • Petrylak DP; Smilow Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
  • Goh JC; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Perez-Gracia J; ICON Research, South Brisbane, Queensland, Australia.
  • Lacombe L; Oncology Department, Clinica Universidad de Navarra, Pamplona, Spain.
  • Zschäbitz S; Department of Surgery, Hôtel-Dieu de Québec, CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
  • Burotto M; Department of Medical Oncology, National Center for Tumor Disease (NCT), University Hospital, Heidelberg, Germany.
  • Mahammedi H; Department of Oncology, Bradford Hill Clinical Research Center, Santiago, Chile.
  • Gravis G; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
  • Bastos DA; Department of Medical Oncology, Institut Paoli-Calmettes Aix-Marseille Université, Marseille, France.
  • McCune SL; Department of Oncology, Hospital Sirio-Libanes, Sao Paulo, Brazil.
  • Vázquez Limón JC; Wellstar Health System Inc, Marietta, Georgia, USA.
  • Kwan EM; Department of Medical Oncology, Instituto Jalisciense de Cancerología, Hospital Civil de Guadalajara, Guadalajara, Mexico.
  • Castellano D; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia.
  • Fléchon A; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Saad F; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Grimm MO; Department of Urology, Centre Hospitalier de l'Université de Montréal/CHUM, Montreal, Quebec, Canada.
  • Shaffer DR; Department of Urology, Jena University Hospital, Jena, Germany.
  • Armstrong AJ; Department of Medical Oncology, New York Oncology Hematology, Albany, New York, USA.
  • Bhagavatheeswaran P; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina, USA.
  • Amin NP; Department of Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Ünsal-Kaçmaz K; Department of Clinical Oncology, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Wang X; Department of Translational Medicine, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Li J; Department of Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Loehr A; Department of Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Pachynski RK; Department of Translational Medicine, Clovis Oncology, Inc, Boulder, Colorado, USA.
J Immunother Cancer ; 10(8)2022 08.
Article em En | MEDLINE | ID: mdl-35977756
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França